Better Med Spa’s retatrutide program delivers a once-weekly triple-agonist peptide (GIP/GLP-1/glucagon) designed to reduce appetite, increase fat burning, and improve metabolic markers. Offered under a non-FDA–approved waiver, this advanced therapy includes physician oversight, labs, and integrated wellness support for qualified clients seeking aggressive, research-backed weight loss.

Retatrutide is a triple hormone receptor agonist that targets GIP, GLP-1, and glucagon receptors, key pathways that regulate appetite, blood sugar, and energy expenditure. By slowing gastric emptying, enhancing glucose-dependent insulin release, suppressing glucagon, and modestly increasing energy burn, it has produced dose-dependent weight loss exceeding 20% of baseline body weight in phase 2 obesity trials. At Better Med Spa, retatrutide is positioned as an advanced peptide protocol: clients complete an informed consent waiver, undergo baseline labs, and follow a carefully titrated dosing schedule with ongoing monitoring and lifestyle coaching.
Retatrutide is designed to address:
Experience the ultimate all-in-one solution:
Experience the best in aesthetic and wellness care at Better Med Spa. Our personalized treatments are tailored to you, designed to help you look and feel your absolute best with confidence and ease.
We're here to answer your questions and provide the best services for your needs.
Retatrutide is a once-weekly triple hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors to simultaneously reduce appetite, improve blood sugar, and increase energy expenditure. Early trials classify it as an advanced anti-obesity peptide because its degree of weight loss and metabolic impact appears greater than many current GLP-1–only or dual-agonist medications.
Retatrutide is not yet FDA-approved for obesity treatment or routine clinical use; it is still under investigation in phase 2–3 trials. At Better Med Spa, retatrutide is offered only under a non-FDA–approved informed consent waiver that explains its investigational status, potential risks, benefits, and alternatives so clients can make a fully informed decision before starting.
Ideal candidates have significant weight to lose, obesity-related risk factors, and a readiness to pair medication with nutrition, movement, and regular monitoring. Each client completes a detailed medical intake, lab work, and consultation to rule out contraindications and to confirm that a non-FDA peptide protocol is clinically appropriate and aligned with personal risk tolerance.
Gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation are the most commonly reported side effects and tend to be dose-related. Trials also report heart rate increases and potential concerns with rapid weight loss, including gallbladder issues and impacts on lean mass, which is why dosing, labs, and symptom tracking are built into Better Med Spa’s protocol.
Clients are enrolled in a structured program that includes baseline and follow-up labs, scheduled check-ins, and access to nutrition and lifestyle coaching to protect muscle, mood, and long-term results. Many choose to bundle retatrutide with memberships that include body-contouring, lymphatic support, and high-performance K-Beauty facials, aligning medical weight loss with skin quality, body shape, and overall confidence.